Publications (214) Publications in which a researcher has participated

2023

  1. Scientific assessment and balance of the 14th Congress and 21st Conference of the Spanish Society of Prison Health held at Jerez de la Frontera, Cadiz

    Revista Espanola de Sanidad Penitenciaria

  2. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

    British Journal of Haematology

2022

  1. Venous thromboembolism in patients with autoimmune disorders: a comparison between bleeding complications during anticoagulation and recurrences after its discontinuation

    British journal of haematology, Vol. 197, Núm. 4, pp. 489-496

  2. Prognostic Impact of Active Cigarette Smoking on Mortality in Patients with Acute Venous Thromboembolic Events, Findings from Real World Data

    Medicina (Lithuania), Vol. 58, Núm. 2

  3. High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use

    Journal of Infection, Vol. 85, Núm. 3, pp. 322-326

  4. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

    Chest, Vol. 161, Núm. 2, pp. 524-534

  5. HEPATITIS C VIRUS SCREENING AND LINKAGE TO CARE IN MENTAL HEALTH UNITS: AN OPPORTUNITY FOR HCV ELIMINATION

    Actas espanolas de psiquiatria, Vol. 50, Núm. 2, pp. 120-121

  6. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

    Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4

  7. Efecto de la administración de diferentes formas de vitamina D en la presión arterial y rigidez aórticas, y su implicación en la reducción de la albuminuria en la enfermedad renal crónica

    Clínica e investigación en arteriosclerosis, Vol. 34, Núm. 6, pp. 311-321

  8. Co-14. Estado actual de la hepatitis delta en andalucía: Estudio multicéntrico

    Revista andaluza de patología digestiva, Vol. 45, Núm. 5, pp. 212-212

  9. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

    JHEP Reports, Vol. 4, Núm. 5

  10. Antioxidant Activity and Polyphenols Content of Artemisia Herba-Alba Extract and their Cytotoxicity against Human Lung Cancer Cells NCI-N417

    Journal of Herbs, Spices and Medicinal Plants, Vol. 28, Núm. 4, pp. 337-350

2021

  1. Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain

    HIV Medicine, Vol. 22, Núm. 5, pp. 379-386

  2. Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV-infected people on opioid agonist therapy

    Journal of Viral Hepatitis, Vol. 28, Núm. 6, pp. 878-886

  3. Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

    Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810

  4. Estimating the health and economic burden of shipping related air pollution in the Iberian Peninsula

    Environment International, Vol. 156

  5. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 2, pp. 408-416

  6. Changes in the Objective Structured Clinical Examination (OSCE) of University Schools of Medicine during COVID-19. Experience with a computer-based case simulation OSCE (CCS-OSCE)

    Revista Clinica Espanola, Vol. 221, Núm. 8, pp. 456-463

  7. Case-control analysis of the impact of anemia on quality of life in patients with cancer: A Qca study analysis

    Cancers, Vol. 13, Núm. 11

  8. Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?

    International Journal of STD and AIDS, Vol. 32, Núm. 13, pp. 1257-1260